Literature DB >> 21108162

[Adherence and cognitive performance in schizophrenia].

A Spiekermann1, M Schulz, J Behrens, M Driessen, E Rahn, T Beblo.   

Abstract

BACKGROUND: It is known that many patients with schizophrenia show non-adherence with regard to antipsychotic medication. Furthermore, many studies indicate cognitive deficits in schizophrenic patients. In this review, we compare the results of studies examining the relationship of non-adherence and cognitive performance.
METHOD: Based on a systematic literature review, the impact of cognitive performance on the adherence behaviour of patients with schizophrenia was examined.
RESULTS: We found 18 studies analysing the impact of cognitive performance on adherence behaviour. Most studies indicated that patients with stronger cognitive impairments show lower adherence behaviour. Possible causal mechanisms are discussed. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21108162     DOI： 10.1055/s-0029-1245622

Source DB:  PubMed          Journal:  Fortschr Neurol Psychiatr        ISSN： 0720-4299            Impact factor:   0.752


  3 in total

Review 1.  Medication adherence in schizophrenia.

Authors:  Francisco Javier Acosta; José Luis Hernández; José Pereira; Judit Herrera; Carlos J Rodríguez
Journal:  World J Psychiatry       Date:  2012-10-22

2.  Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study.

Authors:  Sophie-Kathrin Kirchner; Michael Lauseker; Kristina Adorjan; Heike Anderson-Schmidt; Ion-George Anghelescu; Bernhardt T Baune; Monika Budde; Udo Dannlowski; Detlef E Dietrich; Andreas J Fallgatter; Peter Falkai; Christian Figge; Katrin Gade; Urs Heilbronner; Lena Hiendl; Georg Juckel; Janos L Kalman; Farahnaz Klöhn-Saghatolislam; Carsten Konrad; Fabian U Lang; Mojtaba Oraki Kohshour; Sergi Papiol; Daniela Reich-Erkelenz; Jens Reimer; Eva Z Reininghaus; Sabrina K Schaupp; Max Schmauß; Andrea Schmitt; Eva Christina Schulte; Simon Senner; Carsten Spitzer; Thomas Vogl; Jörg Zimmermann; Alkomiet Hasan; Thomas G Schulze; Fanny Senner
Journal:  Front Psychiatry       Date:  2022-01-20       Impact factor: 4.157

3.  Efficacy of Integrated Social Cognitive Remediation vs. Neurocognitive Remediation in Improving Functional Outcome in Schizophrenia: Concept and Design of a Multicenter, Single-Blind RCT (The ISST Study).

Authors:  Wolfgang Wölwer; Nicole Frommann; Agnes Lowe; Daniel Kamp; Karolin Weide; Andreas Bechdolf; Anke Brockhaus-Dumke; Rene Hurlemann; Ana Muthesius; Stefan Klingberg; Martin Hellmich; Sabine Schmied; Andreas Meyer-Lindenberg
Journal:  Front Psychiatry       Date:  2022-06-21       Impact factor: 5.435
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.